IPO Trending
INFINIUMSME / NSEListed
Infinium Pharmachem

Incorporated in 2003, Infinium Pharmachem Limited manufactures and supplies Iodine Derivatives, APIs, and iodination reaction-based bulk drugs. The company offers R&D services along with commercial-scale manufacturing and packaging for the pharmaceutical, agrochemical, nutraceutical, specialty chemicals, and other chemical industries. Its FDA-certified and GMP-compliant manufacturing facility in Gujarat spans 4,100 sq. m and is equipped to produce complex iodine derivatives. Infinium Pharmachem serves over 15 countries globally, offering more than 200 iodine derivatives and 7 APIs.

₹135 - ₹1351.84x sub
Listed Price₹141.50
Listing Gain+4.81%

Subscription Status

1.84xTotal Demand
Updated 20 Oct 2026, 01:30 AM
Subscription PendingExchange subscription breakup is not available yet.

Category-wise demand has not been published yet. Check back after the exchange updates the live subscription feed.

Open Date31 Mar 2023
Close Date05 Apr 2023
Listing Date17 Apr 2023
Bidding status cross-verified with live IPO subscription numbers ↗BSE & NSE Bidding Portal Feed

About Infinium Pharmachem IPO Subscription Demand

Live subscription status and bidding analysis for Infinium Pharmachem (INFINIUM) IPO. The issue is subscribed 1.84x overall across Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII/HNI), and Retail Individual Investors (RII). Check real-time grey market demand on our GMP Tracker or review full issue details, lot size, and price band on the IPO Details Page.

Frequently Asked Questions